Vaccine may delay recurrence for advanced ovarian cancers

the ONA take:

According to preliminary findings presented at the Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer in Chicago, Illinois, researchers have found that a vaccine delayed cancer recurrence in women with stage III or IV ovarian cancers.

For the phase II study, researchers enrolled 31 women with stage III or IV ovarian cancer. Of those, 20 received the experimental immunotherapy and 11 did not. Results showed that those who did not receive the immunotherapy experienced a cancer recurrence in a median of 14.5 months, while those who did receive the vaccine have not yet reached the median time to recurrence. Thus far, the majority of the study population is beyond the 14.5 months.

"This was a preliminary study with promising results that may give women with advanced ovarian cancer an option for a maintenance regimen," said Jonathan Oh, MD, a gynecologic oncologist at Texas Oncology, P.A., in Dallas, Texas. "Additionally, the vaccine is very well tolerated."

The findings suggest that using a patient's own immune system to combat advanced ovarian cancer may be promising strategy to improve patient outcomes.

Vaccine may delay recurrence for advanced ovarian cancers
Researchers have found that a vaccine delayed cancer recurrence in women with stage III or IV ovarian cancers.
An experimental immunotherapy is in the works that can target an individual woman's tumor and extend the time period between initial treatment and the cancer's return.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs